Current position:Home >Product >
Docosanamide,N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-14-methyl-3-pentadecen-1-yl]-21-methyl-
Docosanamide,N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-14-methyl-3-pentadecen-1-yl]-21-methyl-(155661-02-2)
- Name: Docosanamide,N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-14-methyl-3-pentadecen-1-yl]-21-methyl-
- Synonyms:Docosanamide,N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-14-methyl-3-pentadecenyl]-21-methyl-(9CI); Docosanamide,N-[2-hydroxy-1-(hydroxymethyl)-14-methyl-3-pentadecenyl]-21-methyl-,[R-[R*,S*-(E)]]-; Oceanapin B
- Molecular Formula:C40H79 N O3
- Molecular Weight:
- CAS Registry Number:155661-02-2
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.155661-02-2 Docosanamide,N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-14-methyl-3-pentadecen-1-yl]-21-methyl-
Assay:99% Appearance:White powder Package:25KGS/Drum Storage:Room temperature Transportation:BY SEA Application:API锛孭harmaceutical intermediates
Min. Order:1Gram
Supplier:HENAN NEW BLUE CHEMICAL CO.,LTD [
China (Mainland)]
Other Product
- 97553-62-3/Butanoic acid,4-amino-4-oxo-3-sulfo-, N-coco alkyl derivs., disodium salts
- 7573-17-3/Phenol,2,2',2''-methylidynetris[4-methyl-
- 80761-76-8/N~4~,7,7-trimethyl-7,8-dihydro-6H-pyrimido[4,5-b][1,4]benzothiazine-4,9-diamine hydrobromide
- 133523-26-9/2,4-Cyclopentacycloundecenedione,1,3,3a,5,6,7,8,11,12,12a-decahydro-3a,6,10-trimethyl-1-(1-methylethyl)-,(1S,3aS,6S,9E,12aS)- (9CI)
- 149982-45-6/Propanoic acid, 2-hydroxy-, compd. with N,N-(1-methyl-1,2-ethanediyl)bis(4-((1-(3-(dimethylamino)propyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridinyl)azo)benzamide) acetate (salt)
- 85673-87-6/revenast
- 5986-25-4/Noroxoagarofuran
- 26232-98-4/CIS-4,4-DIMETHYL-2-PENTENE
- 52377-68-1/ETHYL 2-[(4-CHLOROPHENYL)THIO]ACETATE
- 6118-56-5/Benzaldehyde, p-(dimethylamino)-, N-oxide (7CI,8CI)
- 6969-05-7/3-(3-nitrophenyl)-1,5-diphenyl-4,5-dihydro-1H-pyrazole
- 118116-08-8/4-tert-butyl-3-[2-(dibutylamino)ethoxy]phenyl dimethylcarbamate hydrochloride
- 2516-75-8/4-(dimethylsilyl)-N,N-dimethylaniline
- 13908-45-7/3-{[(2-chloroethyl)carbamoyl]amino}benzoic acid
- 78769-16-1/nafocare
- 100208-46-6/disodium [2R-[2R*(4R*,8R*)]]-3,4-dihydro-2,5,8-trimethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl phosphate
- 62191-47-3/6H-Dibenzo[b,d]pyran-1-ol,6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-(octyloxy)-, (6aR,10aR)-
- 4481-10-1/Diphenanthro[9,10-c:9',10'-e]oxepin-17,19-dione(9CI)
- 155661-02-2/Docosanamide,N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-14-methyl-3-pentadecen-1-yl]-21-methyl-
- 21991-02-6/[1,1':2',1''-Terphenyl]-3',5'-dicarboxylicacid
- 1077-04-9/2-amino-6-[(2-hydroxyethyl)amino]pyrimidin-4(1H)-one
- 83495-08-3/methyl 2-methoxy-4-[(E)-[1-(2-methoxy-4-nitro-phenyl)-5-oxo-2-phenyl-i midazol-4-ylidene]methyl]benzoate
- 4837-79-0/Alstovenine
- 62499-98-3/1-(3-hydroxyprop-1-en-1-yl)cyclohexanol
- 1859-71-8/N-(2-benzoylphenyl)-4-methylbenzenesulfonamide
- 156532-79-5/neurexin IIIbeta
- 94231-56-8/Bis(2-hydroxyethyl)ammonium bis(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,14,14,14-tetracosafluoro-13-(trifluoromethyl)tetradecyl) phosphate
- 89456-98-4/[3β-(4-O-Acetyl-β-D-xylopyranosyloxy)-7β-hydroxycucurbita-5,24-dien-16β-yl]6-O-acetyl-β-D-glucopyranoside
- 12266-65-8/Tricosamanganese hexacarbide
- 64178-55-8/6-nitro-3-({[2-(prop-2-en-1-ylsulfanyl)-1,3-benzothiazol-6-yl]amino}methyl)-1,3-benzothiazole-2(3H)-thione